Flow Cytometric Analysis of Platelet Surface Glycoproteins in the Diagnosis of Thirty-two Turkish Patients with Glanzmann Thrombasthenia: a Multicenter Experience

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2021 May 6

PMID 33957723

Citations 2

Authors

Berkay Saraymen

Sabahattin Muhtaroglu

Mustafa Yavuz Koker

Nazan Sarper

Emine Zengin

Canan Albayrak

Davut Albayrak

Bulent Zulfikar

Basak Koc Senol

Esma Bentli

Semih Yilmaz

Aysun Cetin

Bulent Eser

Mustafa Cetin

Affiliations

Soon will be listed here.

Abstract

Background/aim: Glanzmann thrombasthenia (GT) is a rare autosomal recessively inherited bleeding disorder characterized by the quantitative (type 1 and type 2) or qualitative (type 3) deficiency in platelet membrane glycoprotein (GP) IIb/IIIa (CD41a/CD61) fibrinogen receptors. In type 1, 2, and 3, CD41a/CD61 expression is 5%, 5%–20% and above 20%, respectively. In this study, diagnosis of GT was confirmed and subgroups were identified in 32 Turkish patients by flow cytometry analysis.

Materials And Methods: CD41a/CD61 expression levels in platelet-rich plasma (PRP) obtained from peripheral venous EDTA blood samples were analyzed with a BD FACSCanto II flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). GT subgroup analysis was performed by counting 50,000 events in the BD FACSDiva Software v6.1.3 program of the instrument.

Results: In the present study, in blood samples of 32 patients from 23 families with GT and 22 healthy controls, co-expression levels of CD41a and CD61 in PRP was analyzed. 12 out of 23 families were consistent with type 1 GT (52.2%), 4 were consistent with type 2 GT (17.4%), and 7 were consistent with type 3 GT (30.4%).

Conclusion: Especially due to consanguineous marriages, GT with various glycoprotein levels may be detected. As a result of the flow cytometry analysis of the present study with the highest GT patient population in Turkey, type 1 GT patients were the most common subgroup. In the determination of the GT subgroups; especially in the detection of type 3 GT, flow cytometry is the most sensitive glycoprotein analysis method. In addition to light transmission aggregometry, CD41a/CD61 study by flow cytometer confirms diagnosis when mutation analysis cannot be performed.

Citing Articles

Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value.

Cecconello D, Spagnol F, Alegretti A, Pilger D, Farias M Hematol Transfus Cell Ther. 2023; 46 Suppl 5:S136-S142.

PMID: 37652805 PMC: 11670585. DOI: 10.1016/j.htct.2023.07.002.

Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia.

Shen C, Wu Y Tzu Chi Med J. 2022; 34(4):381-387.

PMID: 36578648 PMC: 9791859. DOI: 10.4103/tcmj.tcmj_117_22.

References

George J, Caen J, Nurden A . Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood. 1990; 75(7):1383-95. View

Coller B, Cheresh D, Asch E, Seligsohn U . Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood. 1991; 77(1):75-83. View

Lobo V, Shetty S, Kulkarni B, Butera D, Magalhaes G, Ghosh K . A novel ELISA for diagnosis of Glanzmann's thrombasthenia and the heterozygote carriers. Ann Hematol. 2011; 91(6):917-21. DOI: 10.1007/s00277-011-1390-1. View

Stevens R, Meyer S . Fanconi and Glanzmann: the men and their works. Br J Haematol. 2002; 119(4):901-4. DOI: 10.1046/j.1365-2141.2002.03812.x. View

Patel D, Vaananen H, Jirouskova M, Hoffmann T, Bodian C, Coller B . Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood. 2003; 101(3):929-36. DOI: 10.1182/blood.V101.3.929. View

Dash D, Kumar A, Gupta B . Emergency craniotomy in Glanzmann thrombasthenia: Anesthetic management and brief review of literature. J Anaesthesiol Clin Pharmacol. 2017; 32(4):533-535. PMC: 5187627. DOI: 10.4103/0970-9185.194763. View

Nurden A, Pillois X, Nurden P . Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment. Expert Rev Hematol. 2012; 5(5):487-503. DOI: 10.1586/ehm.12.46. View

Nurden A, Fiore M, Nurden P, Pillois X . Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood. 2011; 118(23):5996-6005. DOI: 10.1182/blood-2011-07-365635. View

Borhany M, Ghazi A, Edwards N, Tabaksert A, Haghighi A, Fatima N . Glanzmann thrombasthenia in Pakistan: molecular analysis and identification of novel mutations. Clin Genet. 2015; 89(2):187-92. PMC: 4737203. DOI: 10.1111/cge.12622. View

10.

Vijapurkar M, Ghosh K, Shetty S, McLane M, Moura da Silva A, Butera D . A simple, novel and robust test to diagnose type I Glanzmann thrombasthenia. Haematologica. 2008; 93(5):797-8. DOI: 10.3324/haematol.12288. View

11.

Kannan M, Ahmad F, Yadav B, Anand M, Jain P, Kumar R . Glanzmann's thrombasthenia in North Indians: sub classification and carrier detection by flow cytometry. Platelets. 2009; 20(1):12-5. DOI: 10.1080/09537100802434853. View

12.

Farsinejad A, Farajollahi M, Kazemi A, Saemi N, Faranoush M . Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran. Blood Coagul Fibrinolysis. 2013; 24(6):613-8. DOI: 10.1097/MBC.0b013e328360a558. View

13.

Nurden A, Caen J . An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol. 1974; 28(2):253-60. DOI: 10.1111/j.1365-2141.1974.tb06660.x. View

14.

Diz-Kucukkaya R . Inherited platelet disorders including Glanzmann thrombasthenia and Bernard-Soulier syndrome. Hematology Am Soc Hematol Educ Program. 2013; 2013:268-75. DOI: 10.1182/asheducation-2013.1.268. View

15.

Poon M, Di Minno G, dOiron R, Zotz R . New Insights Into the Treatment of Glanzmann Thrombasthenia. Transfus Med Rev. 2016; 30(2):92-9. DOI: 10.1016/j.tmrv.2016.01.001. View

16.

Arias-Salgado E, Butta N, Gonzalez-Manchon C, Larrucea S, Ayuso M, Parrilla R . Competition between normal [674C] and mutant [674R] subunits: role of the molecular chaperone BiP in the processing of GPIIb-IIIa complexes. Blood. 2001; 97(9):2640-7. DOI: 10.1182/blood.v97.9.2640. View

17.

LARRIEU M, Caen J, Meyer D, VAINER H, Sultan Y, Bernard J . Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients). Am J Med. 1968; 45(3):354-72. DOI: 10.1016/0002-9343(68)90070-3. View

18.

Nurden A, Nurden P . Inherited disorders of platelets: an update. Curr Opin Hematol. 2006; 13(3):157-62. DOI: 10.1097/01.moh.0000219661.80785.e3. View

19.

Phillips D, Charo I, Parise L, Fitzgerald L . The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988; 71(4):831-43. View

20.

Tokgoz H, Torun Ozkan D, Caliskan U, Akar N . Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia. Platelets. 2015; 26(8):779-82. DOI: 10.3109/09537104.2014.998994. View